These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 76171)

  • 1. Blood-transfusion in group-B streptococcal sepsis.
    Shigeoka AO; Hall RT; Hill HR
    Lancet; 1978 Mar; 1(8065):636-8. PubMed ID: 76171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional leukocyte administration in protection against experimental neonatal infection.
    Santos JI; Shigeoka AO; Hill HR
    Pediatr Res; 1980 Dec; 14(12):1408-10. PubMed ID: 7010290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum opsonic activity and peripheral neutrophil counts before and after exchange transfusion in infants with early onset group B streptococcal septicemia.
    Hall RT; Shigeoka AO; Hill HR
    Pediatr Infect Dis; 1983; 2(5):356-8. PubMed ID: 6356060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neonatal cellular and humoral immunity to group B streptococci.
    Hill HR; Shigeoka AO; Hall RT; Hemming VG
    Pediatrics; 1979 Nov; 64(5 Pt 2 Suppl):787-94. PubMed ID: 388335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Group B streptococcal and pneumococcal sepsis in newborn infants: the role of pneumococcal antibody.
    Fischer GW; Bass JW; Lowell GH; Crumrine MH
    Pediatrics; 1978 Oct; 62(4):620-1. PubMed ID: 30938
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunoprecipitation and opsonic cross-reaction between type-14 pneumococcus and group-B streptococcus type III.
    Fischer GW; Lowell GH; Crumrine MH; Wilson SR
    Lancet; 1979 Jan; 1(8107):75-7. PubMed ID: 84130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous immunoglobulin in neonatal group B streptococcal disease. Pharmacokinetic and safety studies in monkeys and humans.
    Fischer GW; Weisman LB; Hemming VG; London WT; Hunter KW; Bosworth JM; Sever JL; Wilson SR; Curfman BL
    Am J Med; 1984 Mar; 76(3A):117-23. PubMed ID: 6424443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of antibody to native type III polysaccharide of group B Streptococcus in infant infection.
    Baker CJ; Edwards MS; Kasper DL
    Pediatrics; 1981 Oct; 68(4):544-9. PubMed ID: 7033911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoglobulin therapy of neonatal group B streptococcal infections: an overview.
    Fischer GW
    Pediatr Infect Dis J; 1988 May; 7(5 Suppl):S13-6. PubMed ID: 3041355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis of neonatal group B streptococcal infections.
    Baltimore RS
    Yale J Biol Med; 1982; 55(3-4):291-5. PubMed ID: 6758375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of group B streptococcal opsonins in human and rabbit serum by neutrophil chemiluminescence.
    Hemming VG; Hall RT; Rhodes PG; Shigeoka AO; Hill HR
    J Clin Invest; 1976 Dec; 58(6):1379-87. PubMed ID: 62761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection.
    Baker CJ; Kasper DL
    N Engl J Med; 1976 Apr; 294(14):753-6. PubMed ID: 768760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of group B streptococcal opsonins by radiolabeled bacterial uptake.
    Allred CD; Shigeoka AO; Hill HR
    J Immunol Methods; 1979; 26(4):355-63. PubMed ID: 379227
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunological investigation of infants with septicemia or meningitis due to group B Streptococcus.
    Baker CJ; Kasper DL
    J Infect Dis; 1977 Aug; 136 Suppl():S98-104. PubMed ID: 70493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opsonization of group B Streptococcus type III: studies using clinical strains and maternal sera.
    Hastings MJ; Neil J; Easmon CS
    Br J Exp Pathol; 1985 Jun; 66(3):317-23. PubMed ID: 3890914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological aspects of group B streptococcal infections.
    Kretschmer RR; Gotoff SP
    Infection; 1978; 6(4):146-8. PubMed ID: 357294
    [No Abstract]   [Full Text] [Related]  

  • 17. Methods of assessment and importance of opsonic activity for GBS.
    Hill HR; Shigeoka AO; Rote NS; Allred CD; Hemming VG
    Antibiot Chemother (1971); 1985; 35():157-69. PubMed ID: 3901892
    [No Abstract]   [Full Text] [Related]  

  • 18. Complement activation and group B streptococcal infection in the newborn: similarities to endotoxin shock.
    Fenton LJ; Strunk RC
    Pediatrics; 1977 Dec; 60(6):901-7. PubMed ID: 341069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Group B streptococcal neonatal infection.
    Horn KA; Meyer WT; Wyrick BC; Zimmerman RA
    JAMA; 1974 Nov; 230(8):1165-7. PubMed ID: 4608889
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunodeterminant specificity of human immunity to type III group B streptococcus.
    Kasper DL; Baker CJ; Baltimore RS; Crabb JH; Schiffman G; Jennings HJ
    J Exp Med; 1979 Feb; 149(2):327-39. PubMed ID: 84042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.